I10-I15 I20-I25 I26-I28 I30-I52 I70-I79
Conditions
Interventions
Group 1: Intervention group 1:
20-week interest- and experience-based physical activity coaching (total of 10 sessions)
Group 2: Intervention group 2:
20-week cognition-based physical activity coachi
Sponsors
Universität Basel, Departement für Sport, Bewegung und Gesundheit
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Presence of a CVD (coronary heart disease, heart failure, valvular heart disease, implanted cardiac pacemaker) diagnosed by a physician Physician-certified ability to engage in moderate to vigorous physical activity (assessed via routine medical check-up prior to and after participation in Karamba) Completion of the Karamba rehabilitation program Sufficient knowledge of the German language to understand instructions, ability to speak and read in order to complete the questionnaires Internet access for app (e.g. Whatsapp, Zoom, Teams) use to potentially communicate with the coach Prior signed written consent for the patient registry (SwissPR; EC 2019-02057) at University Hospital Basel available Signed written informed consent to participate in the study on a voluntary basis
Exclusion criteria
Exclusion criteria: Patients in primary prevention Medical contraindications to physical activity, as assessed by a practitioner Pregnancy or breastfeeding Current participation in another clinical trial assessing the outcomes of physical activity and lifestyle intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Device-based physical activity at post-intervention and follow-up (6 months after the end of the intervention), as assessed by a Fibion® device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Post- and follow-up-test of self-reported physical activity, as assessed by 7DPAR and BSA-F. Post- and follow-up-test of cardiorespiratory fitness, as assessed by CPET. Post- and follow-up-test of upper-body muscular strength, as assessed by the grip strength test. Post- and follow-up-test of blood pressure, as assessed by an Omron blood pressure monitor. Post- and follow-up-test of body composition, as assessed by body impedance assessment. Post- and follow-up-test of blood glucose, as assessed by point-of-care assessments via finger prick. Post- and follow-up-test of blood lipids, as assessed by point-of-care assessments via finger prick. Follow-up test of three blood markers (CRP; NT-BNP; Troponin T), as assessed by the medical team via blood sampling during KARAMBA and routine clinical follow-up in the outpatient clinic. Post- and follow-up-test of psychological mechanisms (social-cognitive and affective determinants), as assessed by multiple internationally accepted instruments. Post- and follow-up-test of HRQoL, as assessed by SF-12. Post- and follow-up-test of depressive symptom severity, as assessed by PHQ-9. Post- and follow-up-test of cardiac anxiety symptoms, as assessed by CAQ. | — |
Countries
Switzerland
Contacts
Public ContactNicole Braun
Universität Basel, Departement für Sport, Bewegung und Gesundheit
Outcome results
None listed